PTTG1 and Miyoshi myopathy: Additionally, our data suggests that PTTG1 upregulation in MM patients is not a consequence of deletion of the p53 locus 17p13, or associated TP53 mutations [71], which is observed in approximately 10 % of patients and is itself associated with poor prognosis [72–74].